<!--?xml version="1.0" encoding="utf-8"?--><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="plosone"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4839737/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839737/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="PLoS ONE"><meta name="citation_title" content="The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial"><meta name="citation_authors" content="Ruben Poesen, Pieter Evenepoel, Henriette de Loor, Jan A. Delcour, Christophe M. Courtin, Dirk Kuypers, Patrick Augustijns, Kristin Verbeke, Björn Meijers"><meta name="citation_date" content="2016"><meta name="citation_issue" content="4"><meta name="citation_volume" content="11"><meta name="citation_doi" content="10.1371/journal.pone.0153893"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4839737/?report=abstract"><meta name="citation_pmid" content="27100399"><meta name="DC.Title" content="The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Public Library of Science"><meta name="DC.Contributor" content="Ruben Poesen"><meta name="DC.Contributor" content="Pieter Evenepoel"><meta name="DC.Contributor" content="Henriette de Loor"><meta name="DC.Contributor" content="Jan A. Delcour"><meta name="DC.Contributor" content="Christophe M. Courtin"><meta name="DC.Contributor" content="Dirk Kuypers"><meta name="DC.Contributor" content="Patrick Augustijns"><meta name="DC.Contributor" content="Kristin Verbeke"><meta name="DC.Contributor" content="Björn Meijers"><meta name="DC.Date" content="2016"><meta name="DC.Identifier" content="10.1371/journal.pone.0153893"><meta name="DC.Language" content="en"><meta property="og:title" content="The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial"><meta property="og:type" content="article"><meta property="og:description" content="The colonic microbial metabolism is a key contributor to uremic retention solutes accumulating in patients with CKD, relating to adverse outcomes and insulin resistance. Whether prebiotics can reduce intestinal generation of these microbial metabolites ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839737/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4839737/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4839737/pdf/pone.0153893.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1BBB20E8E41B9100000000018F018F.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.ncbi-alerts { background: none repeat scroll 0% 0% #671414;color: #fff;padding: .231em 1.231em;}.ncbi-alerts p { color: #fff; }.ncbi-alerts a, .ncbi-alerts a:visited {color: #fff; background: none;}.ncbi-alerts p {margin: 1em 0;padding: 0 0 0 1.5em; }.ncbi-alerts p:nth-child(1) {background-image: url('/core/icons/information.png');background-position: left top;background-repeat: no-repeat }.ncbi-alerts.subclosed p:nth-child(1) {background-image: url('/core/alerts/warning.png');}.ncbi-alerts.subclosed p { padding-left: 2em;}.ncbi-alerts.pubmed, .ncbi-alerts.pubmed p {background-color: #97B0C8; color: #000;}.ncbi-alerts a { text-decoration: underline !important; }.ncbi-alerts.pubmed a, .ncbi-alerts.pubmed a:visited { color: #000; }.ncbi-alerts, .ncbi-alerts p {background-color: #97B0C8; color: #000;}.ncbi-alerts a, .ncbi-alerts a:visited { color: #000; }</style></head>
    <body class="article" id="ui-ncbiexternallink-4">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4839737%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header" style="margin-bottom: 0px;">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/267609/">v.11(4); 2016</a></li><li class="accid">PMC4839737</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0153893" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">PLoS One</a></span>. 2016; 11(4): e0153893. </span></div><div><span class="fm-vol-iss-date">Published online 2016 Apr 21. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1371%2Fjournal.pone.0153893" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0153893</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4839737</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/27100399">27100399</a></div></div></div></div><h1 class="content-title">The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Poesen%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108734247024" co-class="co-affbox">Ruben Poesen</a>,<sup>1</sup> <a href="/pubmed/?term=Evenepoel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108737880832" co-class="co-affbox">Pieter Evenepoel</a>,<sup>1</sup> <a href="/pubmed/?term=de%20Loor%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108738153696" co-class="co-affbox">Henriette de Loor</a>,<sup>1</sup> <a href="/pubmed/?term=Delcour%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108738151584" co-class="co-affbox">Jan A. Delcour</a>,<sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=Courtin%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108736970656" co-class="co-affbox">Christophe M. Courtin</a>,<sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=Kuypers%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108808835712" co-class="co-affbox">Dirk Kuypers</a>,<sup>1</sup> <a href="/pubmed/?term=Augustijns%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108733200160" co-class="co-affbox">Patrick Augustijns</a>,<sup>4</sup> <a href="/pubmed/?term=Verbeke%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108733198048" co-class="co-affbox">Kristin Verbeke</a>,<sup>3,</sup><sup>5</sup> and  <a href="/pubmed/?term=Meijers%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399" class="affpopup" co-rid="_co_idm140108737097712" co-class="co-affbox">Björn Meijers</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140108734247024"><h3 class="no_margin">Ruben Poesen</h3><p><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Poesen%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Ruben Poesen</a></div></div><div id="_co_idm140108737880832"><h3 class="no_margin">Pieter Evenepoel</h3><p><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Evenepoel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Pieter Evenepoel</a></div></div><div id="_co_idm140108738153696"><h3 class="no_margin">Henriette de Loor</h3><p><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=de%20Loor%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Henriette de Loor</a></div></div><div id="_co_idm140108738151584"><h3 class="no_margin">Jan A. Delcour</h3><p><sup>2</sup>  Department of Microbial and Molecular Systems, Centre for Food and Microbial Technology, University of Leuven, B-3000, Leuven, Belgium</p><p><sup>3</sup>  Leuven Food Science and Nutrition Research Centre (LFoRCe), University of Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Delcour%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Jan A. Delcour</a></div></div><div id="_co_idm140108736970656"><h3 class="no_margin">Christophe M. Courtin</h3><p><sup>2</sup>  Department of Microbial and Molecular Systems, Centre for Food and Microbial Technology, University of Leuven, B-3000, Leuven, Belgium</p><p><sup>3</sup>  Leuven Food Science and Nutrition Research Centre (LFoRCe), University of Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Courtin%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Christophe M. Courtin</a></div></div><div id="_co_idm140108808835712"><h3 class="no_margin">Dirk Kuypers</h3><p><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Kuypers%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Dirk Kuypers</a></div></div><div id="_co_idm140108733200160"><h3 class="no_margin">Patrick Augustijns</h3><p><sup>4</sup>  Department of Pharmaceutical and Pharmacological Sciences, Drug Delivery and Disposition, University of Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Augustijns%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Patrick Augustijns</a></div></div><div id="_co_idm140108733198048"><h3 class="no_margin">Kristin Verbeke</h3><p><sup>3</sup>  Leuven Food Science and Nutrition Research Centre (LFoRCe), University of Leuven, B-3000, Leuven, Belgium</p><p><sup>5</sup>  Translational Research for Gastrointestinal Disorders (Targid), University of Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Verbeke%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Kristin Verbeke</a></div></div><div id="_co_idm140108737097712"><h3 class="no_margin">Björn Meijers</h3><p><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Meijers%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27100399">Björn Meijers</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Kathrin Eller, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140108736307392_ai idm140108734247152_ai idm140108728502704_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140108736307392_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140108736307392_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140108736307392_ai" style="display:none"><div class="fm-affl" lang="en" id="aff001"><sup>1</sup>  Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, B-3000, Leuven, Belgium</div><div class="fm-affl" lang="en" id="aff002"><sup>2</sup>  Department of Microbial and Molecular Systems, Centre for Food and Microbial Technology, University of Leuven, B-3000, Leuven, Belgium</div><div class="fm-affl" lang="en" id="aff003"><sup>3</sup>  Leuven Food Science and Nutrition Research Centre (LFoRCe), University of Leuven, B-3000, Leuven, Belgium</div><div class="fm-affl" lang="en" id="aff004"><sup>4</sup>  Department of Pharmaceutical and Pharmacological Sciences, Drug Delivery and Disposition, University of Leuven, B-3000, Leuven, Belgium</div><div class="fm-affl" lang="en" id="aff005"><sup>5</sup>  Translational Research for Gastrointestinal Disorders (Targid), University of Leuven, B-3000, Leuven, Belgium</div><div class="fm-affl" lang="en" id="edit1">Medical University of Graz, AUSTRIA</div><div id="coi001"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</div><div><p id="__p2" class="p p-first-last">Conceived and designed the experiments: RP PE JAD KV BM. Performed the experiments: RP PE HL BM. Analyzed the data: RP PE HL JAD CMC DK PA KV BM. Contributed reagents/materials/analysis tools: JAD KV. Wrote the paper: RP PE HL JAD CMC DK PA KV BM.</p></div><div id="cor001">* E-mail: <a href="mailto:dev@null" data-email="eb.nevuelzu@srejiem.nrojb" class="oemail">eb.nevuelzu@srejiem.nrojb</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140108736307392_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2016 Jan 13; Accepted 2016 Feb 26.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140108736307392_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2016 Poesen et al</div><div class="license half_rhythm">This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC4839737/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="2" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 CONSORT Checklist: </strong>CONSORT 2010 Checklist AXOS in CKD study. (DOC)</div><div><a href="/pmc/articles/PMC4839737/bin/pone.0153893.s001.doc" data-ga-action="click_feat_suppl">pone.0153893.s001.doc</a><span style="color:gray"> (218K)</span></div><div class="small guid">GUID:&nbsp;349A61C7-9885-4544-BC18-8B8596E35A9D</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 Protocol: </strong>Original protocol AXOS in CKD study. (DOCX)</div><div><a href="/pmc/articles/PMC4839737/bin/pone.0153893.s002.docx" data-ga-action="click_feat_suppl">pone.0153893.s002.docx</a><span style="color:gray"> (114K)</span></div><div class="small guid">GUID:&nbsp;8B4500EB-E549-4684-9D55-BACB54301BBF</div></div></dd></dl><dl data-length="39" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>All relevant data are within the paper.</p></dd></dl></div><div id="idm140108733446464" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140108733446464title">Abstract</h2><!--article-meta--><div><p id="__p3" class="p p-first">The colonic microbial metabolism is a key contributor to uremic retention solutes accumulating in patients with CKD, relating to adverse outcomes and insulin resistance. Whether prebiotics can reduce intestinal generation of these microbial metabolites and improve insulin resistance in CKD patients not yet on dialysis remains unknown. We performed a randomized, placebo-controlled, double-blind, cross-over study in 40 patients with eGFR between 15 and 45 ml/min/1.73 m<sup>2</sup>. Patients were randomized to sequential treatment with prebiotic arabinoxylan oligosaccharides (AXOS) (10 g twice daily) and maltodextrin for 4 weeks, or vice versa, with a 4-week wash-out period between both intervention periods. Serum levels and 24h urinary excretion of <em>p</em>-cresyl sulfate, <em>p</em>-cresyl glucuronide, indoxyl sulfate, trimethylamine N-oxide and phenylacetylglutamine were determined at each time point using liquid chromatography—tandem mass spectrometry. In addition, insulin resistance was estimated by the homeostatic model assessment (HOMA-IR). A total of 39 patients completed the study. We observed no significant effect of AXOS on serum <em>p</em>-cresyl sulfate (<em>P</em> 0.42), <em>p</em>-cresyl glucuronide (<em>P</em> 0.59), indoxyl sulfate (<em>P</em> 0.70) and phenylacetylglutamine (<em>P</em> 0.41) and a small, albeit significant decreasing effect on serum trimethylamine N-oxide (<em>P</em> 0.04). There were neither effect of AXOS on 24h urinary excretion of <em>p</em>-cresyl sulfate (<em>P</em> 0.31), <em>p</em>-cresyl glucuronide (<em>P</em> 0.23), indoxyl sulfate (<em>P</em> 0.87) and phenylacetylglutamine (<em>P</em> 0.43), nor on 24h urinary excretion of trimethylamine N-oxide (<em>P</em> 0.97). In addition, we observed no significant change in HOMA-IR (<em>P</em> 0.93). In conclusion, we could not demonstrate an influence of prebiotic AXOS on microbiota derived uremic retention solutes and insulin resistance in patients with CKD not yet on dialysis. Further study is necessary to elucidate whether prebiotic therapy with other characteristics, higher cumulative exposure or in different patient populations may be of benefit.</p><p id="__p4" class="p p-last"><strong><em>Trial Registration</em></strong>: Clinicaltrials.gov <a id="__tag_772210678" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02141815" ref="reftype=extlink-clinical-trial&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02141815","term_id":"NCT02141815"}}</span>NCT02141815</a></p></div></div><div id="sec001" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec001title">Introduction</h2><p id="__p6" class="p p-first">The uremic milieu is consequential to a disrupted balance between availability of retention solutes and the excretory capacity of the kidney [<a href="#pone.0153893.ref001" rid="pone.0153893.ref001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210662" role="button" aria-expanded="false" aria-haspopup="true">1</a>;<a href="#pone.0153893.ref002" rid="pone.0153893.ref002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210668" role="button" aria-expanded="false" aria-haspopup="true">2</a>]. There is substantial evidence that the colonic microbial metabolism is a key contributor to uremic retention solutes accumulating in patients with chronic kidney disease (CKD) [<a href="#pone.0153893.ref003" rid="pone.0153893.ref003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210645" role="button" aria-expanded="false" aria-haspopup="true">3</a>;<a href="#pone.0153893.ref004" rid="pone.0153893.ref004" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210654" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. Until recently, research has mainly focused on <em>p</em>-cresyl sulfate (PCS) and indoxyl sulfate (IS). PCS originates from microbial fermentation of tyrosine to <em>p</em>-cresol with subsequent endogenous sulfation. Likewise, IS is derived from microbial fermentation of tryptophan to indole, followed by endogenous oxidation and sulfation [<a href="#pone.0153893.ref004" rid="pone.0153893.ref004" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210653" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. Both PCS and IS have repeatedly been associated with overall mortality, cardiovascular disease and progression of pre-existing renal disease [<a href="#pone.0153893.ref005" rid="pone.0153893.ref005" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210664" role="button" aria-expanded="false" aria-haspopup="true">5</a>–<a href="#pone.0153893.ref010" rid="pone.0153893.ref010" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210646" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. <em>p</em>-Cresyl glucuronide (PCG) is another <em>p</em>-cresol derivative formed by endogenous glucuronidation, also relating to worse survival in patients with renal dysfunction [<a href="#pone.0153893.ref011" rid="pone.0153893.ref011" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210670" role="button" aria-expanded="false" aria-haspopup="true">11</a>]. Several other microbiota derived uremic retention solutes have been identified, including trimethylamine N-oxide (TMAO) and phenylacetylglutamine (PAG), which are derived from microbial metabolism of choline and phenylalanine, respectively. Recent data in patients with CKD point to a relationship between cardiovascular disease and serum levels of both TMAO and PAG, while TMAO may also be involved in the development of renal disease [<a href="#pone.0153893.ref012" rid="pone.0153893.ref012" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210648" role="button" aria-expanded="false" aria-haspopup="true">12</a>–<a href="#pone.0153893.ref014" rid="pone.0153893.ref014" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210649" role="button" aria-expanded="false" aria-haspopup="true">14</a>].</p><p id="__p7">Given its importance in uremia, the colonic microbial metabolism is considered a promising, albeit unconventional and largely unexplored therapeutic target in CKD. As reviewed elsewhere, various strategies may impact the colonic microbial metabolism, including prebiotics [<a href="#pone.0153893.ref015" rid="pone.0153893.ref015" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210658" role="button" aria-expanded="false" aria-haspopup="true">15</a>]. Prebiotics are generally defined as selectively fermented ingredients that result in specific changes in the composition and/or activity of the gastrointestinal microbiota (i.e., mainly bifidobacteria), thus conferring benefit(s) upon host health, which is mainly derived from a shift from protein fermentation to carbohydrate fermentation [<a href="#pone.0153893.ref016" rid="pone.0153893.ref016" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210652" role="button" aria-expanded="false" aria-haspopup="true">16</a>]. Previously, we have demonstrated a decreasing effect of prebiotic oligofructose-enriched inulin on serum levels of PCS, but not IS, in hemodialysis patients [<a href="#pone.0153893.ref017" rid="pone.0153893.ref017" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210660" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. Recently, a reduction in serum levels of IS and, possibly, PCS in hemodialysis patients has also been observed with resistant starch [<a href="#pone.0153893.ref018" rid="pone.0153893.ref018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210671" role="button" aria-expanded="false" aria-haspopup="true">18</a>].</p><p id="__p8" class="p p-last">Whether prebiotic therapy is beneficial in patients with CKD not yet on dialysis remains unknown. Only one preclinical animal study has explored the effect of prebiotics in moderate CKD [<a href="#pone.0153893.ref019" rid="pone.0153893.ref019" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210644" role="button" aria-expanded="false" aria-haspopup="true">19</a>]. In mice with normal renal function, it has been shown by Koppe <em>et al</em>. that PCS in uremic concentrations triggers insulin resistance, loss of fat mass and ectopic redistribution of lipid in muscle and liver, mimicking features observed in mice after induction of 5/6<sup>th</sup> nephrectomy. Interestingly, when arabinoxylan oligosaccharides (AXOS), which has prebiotic characteristics as summarized by Broekaert <em>et al</em>. [<a href="#pone.0153893.ref020" rid="pone.0153893.ref020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210669" role="button" aria-expanded="false" aria-haspopup="true">20</a>], was administered to 5/6<sup>th</sup> nephrectomy mice, these metabolic derangements were reversed with a concomitant reduction in serum PCS. Our research groups have previously performed several studies with AXOS in healthy volunteers, demonstrating good tolerability and confirming their prebiotic potential, as demonstrated by increased fecal bifidobacteria levels, increased short-chain fatty acid production, diminished fecal pH and reduction in 24h urinary excretion of <em>p</em>-cresol/PCS, which under steady state conditions is a proxy for the intestinal exposure [<a href="#pone.0153893.ref020" rid="pone.0153893.ref020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210661" role="button" aria-expanded="false" aria-haspopup="true">20</a>–<a href="#pone.0153893.ref023" rid="pone.0153893.ref023" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210672" role="button" aria-expanded="false" aria-haspopup="true">23</a>]. Given the clinical data in healthy individuals and the preclinical data in an animal model of moderate CKD, the ‘AXOS in CKD study’ was designed to investigate the influence of AXOS in patients with CKD not yet on dialysis, thereby focusing on various microbiota derived uremic retention solutes and the occurrence of insulin resistance.</p></div><div id="sec002" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec002title">Materials and Methods</h2><div id="sec003" class="sec sec-first"><h3 id="sec003title">Study population</h3><p id="__p9" class="p p-first-last">CKD patients with an estimated glomerular filtration rate (eGFR) between 15 and 45 ml/min/1.73 m<sup>2</sup>, followed at the nephrology outpatient clinic of the University Hospitals Leuven, Belgium, were enrolled in the study (clinicaltrials.gov <a id="__tag_772210677" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02141815" ref="reftype=extlink-clinical-trial&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02141815","term_id":"NCT02141815"}}</span>NCT02141815</a>). Eligible patients were 18 years or older and able to give written informed consent. Patients with known gastro-intestinal disease (i.e., inflammatory bowel disease, malignancy), previous colorectal surgery and insulin-dependent diabetes mellitus were excluded. Use of antibiotics, prebiotics or probiotics in the past 4 weeks was not allowed. The study was performed according to the Declaration of Helsinki and approved by the Ethics Committee (ML9503) of the University Hospitals Leuven. Written informed consent was obtained from all patients.</p></div><div id="sec004" class="sec"><h3 id="sec004title">Study design</h3><p id="__p10" class="p p-first">Figs <a href="/pmc/articles/PMC4839737/figure/pone.0153893.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0153893.g001" rid-ob="ob-pone.0153893.g001" co-legend-rid="lgnd_pone.0153893.g001"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -2em;">Figs1</span></span><span>1</span></a> and <a href="/pmc/articles/PMC4839737/figure/pone.0153893.g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0153893.g002" rid-ob="ob-pone.0153893.g002" co-legend-rid="lgnd_pone.0153893.g002"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2</span></span><span>2</span></a> present the randomized, placebo-controlled, double-blind, cross-over study design (<a href="#pone.0153893.s001" rid="pone.0153893.s001" class=" supplementary-material">S1 CONSORT Checklist</a> and S2 Protocol). After enrollment (performed by RP), patients were randomized by the study nurse, blinded from both the investigator and study participant. Randomization was performed by the sealed envelope system, in which the study nurse randomly opened a preformed envelope containing the allocated treatment regimen. Patients were allocated to sequential treatment with AXOS and placebo, or vice versa, with a wash-out period between both intervention periods. Treatment with AXOS or placebo was offered to patients in identical vials and boxes. Each box was also labeled with a numerical code, unique to treatment allocation and again blinded from both the investigator and study participant, as an additional measure to allow review of the correct treatment allocation by the study nurse. The duration of each intervention and wash-out period was 4 weeks with a total study duration of 12 weeks. At each time point, we collected blood (fasting), 24h urine, food frequency questionnaires (i.e., dietary habits during the past 4 weeks), and information regarding body weight, stool frequency and consistency (i.e., Bristol stool scale). After each intervention period, tolerance was assessed by five-level Likert item questionnaires for overall tolerance, study treatment intake, abdominal discomfort, abdominal cramps, abdominal bloating, flatulence, nausea and diarrhea. To evaluate safety, there was also clinical and additional biochemical (i.e., creatinine, C-reactive protein, alanine aminotransferase, potassium) follow-up at each time point.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0153893.g001" co-legend-rid="lgnd_pone.0153893.g001"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g001/" target="figure" rid-figpopup="pone.0153893.g001" rid-ob="ob-pone.0153893.g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108733486960" class="figure"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g001/" target="figure" rid-figpopup="pone.0153893.g001" rid-ob="ob-pone.0153893.g001"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4839737_pone.0153893.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0153893.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4839737/bin/pone.0153893.g001.jpg"></a></div><div id="largeobj_idm140108733486960" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4839737/figure/pone.0153893.g001/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0153893.g001"><div><a class="figpopup" href="/pmc/articles/PMC4839737/figure/pone.0153893.g001/" target="figure" rid-figpopup="pone.0153893.g001" rid-ob="ob-pone.0153893.g001">Fig 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>CONSORT flow diagram.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0153893.g002" co-legend-rid="lgnd_pone.0153893.g002"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g002/" target="figure" rid-figpopup="pone.0153893.g002" rid-ob="ob-pone.0153893.g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108738391296" class="figure"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g002/" target="figure" rid-figpopup="pone.0153893.g002" rid-ob="ob-pone.0153893.g002"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4839737_pone.0153893.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0153893.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4839737/bin/pone.0153893.g002.jpg"></a></div><div id="largeobj_idm140108738391296" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4839737/figure/pone.0153893.g002/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0153893.g002"><div><a class="figpopup" href="/pmc/articles/PMC4839737/figure/pone.0153893.g002/" target="figure" rid-figpopup="pone.0153893.g002" rid-ob="ob-pone.0153893.g002">Fig 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Study design.</strong><p id="__p11">Schematic representation of the study design. AXOS, arabinoxylan oligosaccharides; BID, twice a day.</p></div></div></div></div><div id="sec005" class="sec"><h3 id="sec005title">Study treatment</h3><p id="__p12" class="p p-first-last">Active treatment consisted of AXOS 10 g twice daily, which were obtained from commercial wheat bran. The composition of AXOS and the procedures for their characterization are described elsewhere [<a href="#pone.0153893.ref024" rid="pone.0153893.ref024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210657" role="button" aria-expanded="false" aria-haspopup="true">24</a>]. Maltodextrin (Paselli MD 6, Avebe, Veendam, The Netherlands), an oligosaccharide obtained by enzymatic hydrolysis of potato starch with total digestion in the small intestine, was used as placebo in equal volumes as AXOS (i.e., approximately 6.7 g twice daily). Both AXOS and maltodextrin were dissolved in 200 ml water prior to consumption.</p></div><div id="sec006" class="sec"><h3 id="sec006title">Biochemical measurements</h3><p id="__p13" class="p p-first-last">At each time-point, blood (fasting) was taken by venous puncture for measurement of creatinine (mg/dl), urea (mg/dl), glucose (mg/dl), insulin (mU/l), C-reactive protein (mg/l), alanine aminotransferase (U/l), potassium (mmol/l), PCS (μM), PCG (μM), IS (μM), TMAO (μM) and PAG (μM). Creatinine (mg/dl), urea (mg/dl), glucose (mg/dl), insulin (mU/l), C-reactive protein (mg/l), alanine aminotransferase (U/l) and potassium (mmol/l) were measured using standard laboratory techniques. The eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [<a href="#pone.0153893.ref025" rid="pone.0153893.ref025" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210643" role="button" aria-expanded="false" aria-haspopup="true">25</a>]. Insulin resistance was estimated by the homeostatic model assessment (HOMA-IR), which approximates the insulin—glucose product, divided by 405 [<a href="#pone.0153893.ref026" rid="pone.0153893.ref026" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210674" role="button" aria-expanded="false" aria-haspopup="true">26</a>]. Serum levels of PCS, PCG, IS, PAG and TMAO were quantified using a dedicated ultra-performance liquid chromatography—tandem mass spectrometry (UPLC—MS/MS) (Acquity—Xevo TQS, Waters, Zellik, Belgium) method. For sample preparation, 50 μl serum, 50 μl solution of MQ water/MeOH/0.01 N sodium hydroxide (% v/v 75/20/5), 20 μl of internal standard mixture (PCS-d7, PCG-d4, IS-d4, TMAO-d9 and PAG-d5) and 150 μl acetonitrile were thoroughly mixed in 96-well Ostro plates (Waters, Zellik, Belgium). Supernatants were collected, dried and after dilution with 1000 μl MQ water, injected on the UPLC-MS/MS system. Chromatographic separation was performed on an Acquity CSHFluoroPhenyl column (Waters, Zellik, Belgium). The mobile phase, delivered at a flow rate of 0.5 ml/min at 40°C, consisted of a gradient of 0.1% formic acid in MQ water (A) and MeOH (B). Ionization of PCS, PCG, IS, PAG and their corresponding isotopologues (internal standards) was achieved in negative mode, while ionization of TMAO and TMAO-d9 was performed in positive mode. The total, within-run, between-run and between-day method imprecision, according to the NCCLS EP5-T guideline, were below 10% for all compounds while their mean recoveries were between 96 and 101%. With availability of 24h urinary collections at each time point, we also measured 24h urinary excretion of urea, PCS, PCG, IS, TMAO and PAG. Assuming steady state conditions and negligible non-renal clearance, 24h urinary excretion can be considered to be an estimate of the daily intestinal uptake of microbial metabolites.</p></div><div id="sec007" class="sec"><h3 id="sec007title">Study endpoints</h3><p id="__p14" class="p p-first-last">Primary efficacy endpoint was the effect of AXOS on serum levels of microbial metabolites. As secondary endpoints, we investigated both 24h urinary excretion of microbial metabolites and HOMA-IR. A sample size of 26 patients was expected to provide 80% power (two-sided, α = 0.05) for detection of a significant reduction of 10 μM in serum PCS. To anticipate potential drop-out, we aimed to include a total of 40 patients.</p></div><div id="sec008" class="sec sec-last"><h3 id="sec008title">Statistics</h3><p id="__p15" class="p p-first-last">Data are expressed as mean (SD) for normally distributed variables or median (interquartile range [IQR]) for non-normally distributed variables. In an intention-to-treat analysis, treatment effect was tested using mixed models. For each variable, post-intervention value was considered the dependent variable with treatment, within-subject period and pre-intervention value entered as fixed effects into the model. Differences in post-intervention tolerance measurements (i.e., five-level Likert items) were evaluated by Fisher’s exact test. For all statistical analyses, <em>P</em>-values less than 0.05 were considered significant. All statistical analyses were performed using SAS (version 9.3, the SAS institute, Cary, NC).</p></div></div><div id="sec009" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec009title">Results</h2><div id="sec010" class="sec sec-first"><h3 id="sec010title">Study population</h3><p id="__p16" class="p p-first">Between May 2014 and March 2015, a total of 40 patients were included in the study. <a href="/pmc/articles/PMC4839737/table/pone.0153893.t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0153893.t001" rid-ob="ob-pone.0153893.t001" co-legend-rid=""><span>Table 1</span></a> lists the baseline characteristics. Vascular (18 patients) and glomerular disease (8 patients) were the most prevalent underlying renal diseases. Seven patients were treated with oral antidiabetic drugs. During study, there were no significant differences in total calorie intake (<em>P</em> 0.95), intake of protein (<em>P</em> 0.57), carbohydrate (<em>P</em> 0.90), fiber (<em>P</em> 0.32) and fat (<em>P</em> 0.85), and body weight (<em>P</em> 0.13), when either AXOS or placebo was given as intervention.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0153893.t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Study population.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108733481680" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Variabele</th><th align="left" rowspan="1" colspan="1">Mean (SD) or median (IQR)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (yr)</td><td align="left" rowspan="1" colspan="1">70 (6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender: male/female (%)</td><td align="left" rowspan="1" colspan="1">28/12 (70/30)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">28.7 (5.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dl)</td><td align="left" rowspan="1" colspan="1">1.98 (1.60–2.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR (ml/min per 1.73 m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">33 (27–38)</td></tr><tr><td align="left" rowspan="1" colspan="1">24h proteinuria (g)</td><td align="left" rowspan="1" colspan="1">0.161 (0.078–0.498)</td></tr><tr><td align="left" rowspan="1" colspan="1">Calories (Kcal/day)</td><td align="left" rowspan="1" colspan="1">1473.8 (412.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (g/day)</td><td align="left" rowspan="1" colspan="1">57.7 (18.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrate (g/day)</td><td align="left" rowspan="1" colspan="1">186.0 (54.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fiber (g/day)</td><td align="left" rowspan="1" colspan="1">18.8 (7.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (g/day)</td><td align="left" rowspan="1" colspan="1">52.4 (17.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urea (mg/dl)</td><td align="left" rowspan="1" colspan="1">65.5 (51.0–75.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum <em>p</em>-cresyl sulfate (μM)</td><td align="left" rowspan="1" colspan="1">52.0 (25.5–76.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum <em>p</em>-cresyl glucuronide (μM)</td><td align="left" rowspan="1" colspan="1">0.18 (0.10–0.35)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum indoxyl sulfate (μM)</td><td align="left" rowspan="1" colspan="1">10.9 (7.6–15.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum trimethylamine N-oxide (μM)</td><td align="left" rowspan="1" colspan="1">8.9 (7.1–12.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum phenylacetylglutamine (μM)</td><td align="left" rowspan="1" colspan="1">6.5 (3.6–8.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (fasting) (mg/dl)</td><td align="left" rowspan="1" colspan="1">98 (93–104)</td></tr><tr><td align="left" rowspan="1" colspan="1">Insuline (fasting) (mU/l)</td><td align="left" rowspan="1" colspan="1">10.9 (7.3–16.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR</td><td align="left" rowspan="1" colspan="1">2.7 (1.7–4.4)</td></tr></tbody></table></div><div id="largeobj_idm140108733481680" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4839737/table/pone.0153893.t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t001fn001"><p id="__p17" class="p p-first-last">eGFR, estimated GFR; HOMA-IR; homeostatic homeostasis model assessment-estimated insulin resistance.</p></div></div></div></div><div id="sec011" class="sec"><h3 id="sec011title">Compliance and tolerance</h3><p id="__p18" class="p p-first-last">Overall, compliance was excellent with intake of 96.6% of AXOS doses and 97.9% of placebo doses. One patient prematurely ended the study due to declared nausea during intervention with AXOS in the first period. In general, tolerance was good with no significant differences in overall tolerance (<em>P</em> 0.13), study treatment intake (<em>P</em> 0.07), abdominal discomfort (<em>P</em> 0.30), abdominal cramps (<em>P</em> 1.00), abdominal bloating (<em>P</em> 0.27), nausea (<em>P</em> 0.23) and diarrhea (<em>P</em> 1.00), when either AXOS or placebo was given as intervention. We, however, noted a significant change in flatulence (<em>P</em> &lt; 0.001) with an increase in flatulence (i.e., Likert scale 4 and 5) in 30 versus 20 patients during intake of AXOS and placebo, respectively. Stool frequency (<em>P</em> 0.92) and consistency (<em>P</em> 0.62) were not significantly different between both interventions. Biochemically, there was no significant change in serum creatinine (<em>P</em> 0.91), C-reactive protein (<em>P</em> 0.37) and potassium (<em>P</em> 0.47), although we noted a small, albeit significant decrease in alanine aminotransferase (<em>P</em> 0.03).</p></div><div id="sec012" class="sec"><h3 id="sec012title">Serum levels and 24h urinary excretion of microbial metabolites</h3><p id="__p19" class="p p-first">As primary endpoint, the influence of AXOS versus placebo on serum levels of microbial metabolites was explored (<a href="/pmc/articles/PMC4839737/table/pone.0153893.t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0153893.t002" rid-ob="ob-pone.0153893.t002" co-legend-rid=""><span>Table 2</span></a>). We observed no significant change in serum PCS (<em>P</em> 0.42), PCG (<em>P</em> 0.59), IS (<em>P</em> 0.70), and PAG (<em>P</em> 0.41) (<a href="/pmc/articles/PMC4839737/figure/pone.0153893.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0153893.g003" rid-ob="ob-pone.0153893.g003" co-legend-rid="lgnd_pone.0153893.g003"><span>Fig 3</span></a>). There was a small, albeit significant decreasing effect of AXOS on serum TMAO (<em>P</em> 0.04). No effect was noted on urea (<em>P</em> 0.44). As secondary endpoint, we also considered 24h urinary excretion of microbial metabolites with no significant change in 24h urinary excretion of PCS (<em>P</em> 0.31), PCG (<em>P</em> 0.23), IS (<em>P</em> 0.87) and PAG (<em>P</em> 0.43) (<a href="/pmc/articles/PMC4839737/table/pone.0153893.t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0153893.t003" rid-ob="ob-pone.0153893.t003" co-legend-rid=""><span>Table 3</span></a>). In contrast to what was noted for serum TMAO, there was no effect of AXOS on 24h urinary excretion of TMAO (<em>P</em> 0.97). Again, we observed no significant effect on 24h urinary excretion of urea (<em>P</em> 0.08). When only taking into account patients with initial lower than median fiber intake, there were neither differences in serum levels nor in 24h urinary excretion of any of the microbial metabolites (data not shown).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0153893.t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Influence of arabinoxylan oligosaccharides (AXOS) on serum levels of microbial metabolites.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108735874784" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Solute</th><th align="left" rowspan="1" colspan="1">Treatment effect (AXOS vs. placebo) (95% confidence interval)</th><th align="left" rowspan="1" colspan="1"><em>P</em></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Urea (Ln)</td><td align="left" rowspan="1" colspan="1">0.035 (- 0.056–0.127)</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1"><em>p</em>-Cresyl sulfate (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.115 (- 0.401–0.171)</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1"><em>p</em>-Cresyl glucuronide (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.105 (- 0.496–0.286)</td><td align="center" rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" rowspan="1" colspan="1">Indoxyl sulfate (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.031 (- 0.198–0.136)</td><td align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Trimethylamine N-oxide (Ln)(Ln)(Ln)</td><td align="left" rowspan="1" colspan="1">- 0.237 (- 0.464–0.010)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Phenylacetylglutamine (Ln)</td><td align="left" rowspan="1" colspan="1">0.080 (- 0.115–0.275)</td><td align="center" rowspan="1" colspan="1">0.41</td></tr></tbody></table></div><div id="largeobj_idm140108735874784" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4839737/table/pone.0153893.t002/?report=objectonly">Open in a separate window</a></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0153893.g003" co-legend-rid="lgnd_pone.0153893.g003"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g003/" target="figure" rid-figpopup="pone.0153893.g003" rid-ob="ob-pone.0153893.g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108734198896" class="figure"><a href="/pmc/articles/PMC4839737/figure/pone.0153893.g003/" target="figure" rid-figpopup="pone.0153893.g003" rid-ob="ob-pone.0153893.g003"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4839737_pone.0153893.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0153893.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4839737/bin/pone.0153893.g003.jpg"></a></div><div id="largeobj_idm140108734198896" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4839737/figure/pone.0153893.g003/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0153893.g003"><div><a class="figpopup" href="/pmc/articles/PMC4839737/figure/pone.0153893.g003/" target="figure" rid-figpopup="pone.0153893.g003" rid-ob="ob-pone.0153893.g003">Fig 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Serum levels of microbial metabolites during treatment with arabinoxylan oligosaccharides (AXOS).</strong><p id="__p20">Evolution of serum urea (A), <em>p</em>-cresyl sulfate (B), <em>p</em>-cresyl glucuronide (C), indoxyl sulfate (D), trimethylamine N-oxide (E) and phenylacetylglutamine (F) during treatment with AXOS.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0153893.t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Influence of arabinoxylan oligosaccharides (AXOS) on 24h urinary excretion of microbial metabolites.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108723682688" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Solute</th><th align="left" rowspan="1" colspan="1">Treatment effect (AXOS vs. placebo) (95% confidence interval)</th><th align="left" rowspan="1" colspan="1"><em>P</em></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of urea (Ln)</td><td align="left" rowspan="1" colspan="1">0.091 (- 0.012–0.194)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of <em>p</em>-cresyl sulfate (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.128 (- 0.382–0.126)</td><td align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of <em>p</em>-cresyl glucuronide (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.291 (- 0.776–0.194)</td><td align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of indoxyl sulfate (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.015 (- 0.213–0.182)</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of trimethylamine N-oxide (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.007 (- 0.410–0.396)</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">24h urinary excretion of phenylacetylglutamine (Ln)</td><td align="left" rowspan="1" colspan="1">0.090 (- 0.137–0.318)</td><td align="center" rowspan="1" colspan="1">0.43</td></tr></tbody></table></div><div id="largeobj_idm140108723682688" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4839737/table/pone.0153893.t003/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec013" class="sec sec-last"><h3 id="sec013title">Insulin resistance</h3><p id="__p21" class="p p-first">As co-secondary endpoint in the study, we analyzed the influence of AXOS versus placebo on insulin resistance, as determined by HOMA-IR (fasting) (<a href="/pmc/articles/PMC4839737/table/pone.0153893.t004/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0153893.t004" rid-ob="ob-pone.0153893.t004" co-legend-rid=""><span>Table 4</span></a>). We observed no significant change in HOMA-IR (<em>P</em> 0.93), neither in levels of insulin (<em>P</em> 0.87), nor in those of glucose (<em>P</em> 0.73). In subgroup analysis of patients with initial lower than median fiber intake, there were also no differences in any of the 3 parameters of insulin resistance (data not shown). No effect on HOMA-IR, insulin and glucose was noted when also excluding patients on oral antidiabetic drugs (data not shown).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0153893.t004"><h3>Table 4</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Influence of arabinoxylan oligosaccharides (AXOS) on insulin resistance.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140108723869008" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Solute</th><th align="left" rowspan="1" colspan="1">Treatment effect (AXOS vs. placebo) (95% confidence interval)</th><th align="left" rowspan="1" colspan="1"><em>P</em></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HOMA-IR (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.011 (- 0.259–0.237)</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (fasting) (Ln)</td><td align="left" rowspan="1" colspan="1">- 0.020 (- 0.261–0.222)</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (fasting) (Ln)</td><td align="left" rowspan="1" colspan="1">0.010 (- 0.049–0.070)</td><td align="center" rowspan="1" colspan="1">0.73</td></tr></tbody></table></div><div id="largeobj_idm140108723869008" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4839737/table/pone.0153893.t004/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t004fn001"><p id="__p22" class="p p-first-last">HOMA-IR; homeostatic homeostasis model assessment-estimated insulin resistance.</p></div></div></div></div></div><div id="sec014" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec014title">Discussion</h2><p id="__p23" class="p p-first">In the ‘AXOS in CKD study’, we explored the influence of prebiotic AXOS in patients with CKD not yet on dialysis. The key findings are as follows: (i) overall tolerance of AXOS is excellent; (ii) there is no effect of AXOS on serum levels and 24h urinary excretion of PCS, PCG, IS, TMAO and PAG as markers of microbiota derived uremic retention solutes; (iii) there is no effect of AXOS on insulin resistance.</p><p id="__p24">The colonic microbial metabolism is a key contributor to the syndrome of uremia and various microbial metabolites, including PCS, PCG, IS, TMAO and PAG, have been related to adverse outcomes in patients with varying degrees of renal dysfunction [<a href="#pone.0153893.ref003" rid="pone.0153893.ref003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210663" role="button" aria-expanded="false" aria-haspopup="true">3</a>–<a href="#pone.0153893.ref014" rid="pone.0153893.ref014" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210650" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. Due to their colonic origin, there is an opportunity to target these solutes at their site of production, for example by means of prebiotics. In a pilot study in hemodialysis patients (<em>n</em> = 22, uncontrolled), we have earlier demonstrated a significant reduction in serum PCS, but not IS, after intake of a mixture of oligofructose-enriched inulin [<a href="#pone.0153893.ref017" rid="pone.0153893.ref017" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210665" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. In another study in hemodialysis patients (<em>n</em> = 56, placebo-controlled), Sirich <em>et al</em>. noted that resistant starch significantly decreases serum IS and, possibly, also PCS [<a href="#pone.0153893.ref018" rid="pone.0153893.ref018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210659" role="button" aria-expanded="false" aria-haspopup="true">18</a>]. It can, however, be hypothesized that prebiotic therapy would be more beneficial in patients at earlier stages of CKD. Indeed, the deleterious effects of these microbial metabolites may not yet have been established and, therefore, may possibly be prevented. To the best of our knowledge, only one small study investigated the effect of prebiotics (i.e., inulin) in patients with CKD not yet on dialysis (<em>n</em> = 13, placebo-controlled cross-over) [<a href="#pone.0153893.ref027" rid="pone.0153893.ref027" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210655" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. The study demonstrated a significant decrease in serum <em>p</em>-cresol/PCS, while the effect on other microbial metabolites was not studied. We performed a randomized placebo-controlled cross-over study with AXOS, another prebiotic selected based on preclinical and clinical data, in 40 patients with eGFR between 15 and 45 ml/min/1.73 m<sup>2</sup>. We found no effect of AXOS on serum levels of PCS, PCG, IS and PAG, and only a borderline significant effect (not adjusted for multi-comparison) on serum levels of TMAO. There was no influence of AXOS on 24h urinary excretion of any of the microbial metabolites. These findings are at odds with previous observations in healthy volunteers which demonstrated a significant decrease in 24h urinary excretion of <em>p</em>-cresol/PCS as an estimate of the daily intestinal uptake [<a href="#pone.0153893.ref020" rid="pone.0153893.ref020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210651" role="button" aria-expanded="false" aria-haspopup="true">20</a>–<a href="#pone.0153893.ref023" rid="pone.0153893.ref023" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210673" role="button" aria-expanded="false" aria-haspopup="true">23</a>]. It remains to be elucidated why AXOS exerts a beneficial effect in healthy volunteers, but not in patients with CKD not yet on dialysis. As alterations in diet during study could interfere with potential treatment effects, dietary changes were formally excluded. Compliance was also excellent. Although cumulative exposure to AXOS was higher in the current study, it can be hypothesized that the colonic microbial metabolism in CKD may be more resistant to short-term intake of AXOS. Our teams have previously shown a distinct colonic microbial metabolism in hemodialysis patients [<a href="#pone.0153893.ref028" rid="pone.0153893.ref028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210656" role="button" aria-expanded="false" aria-haspopup="true">28</a>], but little is known about potential changes in patients at earlier stages of CKD, although it seems plausible that the shift in microbial metabolism is less pronounced than in hemodialysis patients. Therefore, as an effect of other types of prebiotics, i.e., inulin and resistant starch, has been demonstrated in hemodialysis patients [<a href="#pone.0153893.ref017" rid="pone.0153893.ref017" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210667" role="button" aria-expanded="false" aria-haspopup="true">17</a>;<a href="#pone.0153893.ref018" rid="pone.0153893.ref018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210666" role="button" aria-expanded="false" aria-haspopup="true">18</a>], it can also be suggested that these prebiotics are more powerful than AXOS, although direct comparison in patients with varying degrees of renal dysfunction requires further study.</p><p id="__p25">In addition, as experimental studies have suggested that AXOS may diminish CKD-related insulin resistance, whether or not due to a concomitant decline in serum PCS [<a href="#pone.0153893.ref019" rid="pone.0153893.ref019" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_772210647" role="button" aria-expanded="false" aria-haspopup="true">19</a>], we explored the potential effect of AXOS on HOMA-IR, which is commonly used to estimate insulin resistance. Again, we could not demonstrate a beneficial effect after intake of AXOS, possibly due to the lack of effect on serum PCS. Whether other types of prebiotics may affect insulin resistance in CKD remains to be explored.</p><p id="__p26">There are limitations to our study. First, to explore the influence of AXOS on microbiota derived uremic retention solutes, we focused on PCS, PCG, IS, TMAO and PAG as the most important representatives of this group of solutes. We cannot exclude effects of AXOS on other microbial metabolites. Second, fecal samples were not collected, precluding direct statements about the influence of AXOS on colonic microbial metabolism. Third, HOMA-IR was chosen as the marker of insulin resistance, which may fail to detect more subtle changes in glucose homeostasis. As serial measurements of lipid parameters were also not available in our study, the potential beneficial influence of AXOS on dyslipidemia was not explored. Finally, our study population mainly consisted of patients of Caucasian origin. Care must be taken to extrapolate our data to other patient populations.</p><p id="__p27" class="p p-last">In conclusion, we could not demonstrate an influence of the prebiotic AXOS on microbiota derived uremic retention solutes and insulin resistance in patients with CKD not yet on dialysis. Further study is necessary to elucidate whether prebiotic therapy with other characteristics, higher cumulative exposure or in different patient populations may be of benefit.</p></div><div id="sec015" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec015title">Supporting Information</h2><!--/article/body/sec/--><div class="sec suppmat" id="pone.0153893.s001"><h4>S1 CONSORT Checklist</h4><!--caption a9--><strong>CONSORT 2010 Checklist AXOS in CKD study. </strong><p id="__p28">(DOC)</p><div class="sup-box half_rhythm" id="idm140108772320608"><a href="/pmc/articles/PMC4839737/bin/pone.0153893.s001.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(218K, doc)</sup></div></div><div class="sec suppmat" id="pone.0153893.s002"><h4>S1 Protocol</h4><!--caption a9--><strong>Original protocol AXOS in CKD study. </strong><p id="__p30">(DOCX)</p><div class="sup-box half_rhythm" id="idm140108728126000"><a href="/pmc/articles/PMC4839737/bin/pone.0153893.s002.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(114K, docx)</sup></div></div></div><div id="idm140108773196160" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140108773196160title">Acknowledgments</h2><div class="sec"><p id="__p32">RP is the recipient of a Ph.D. fellowship of the Research Foundation—Flanders (FWO) (grant 11E9813N). Part of the research has been funded by the Research Foundation—Flanders (FWO) (grant G077514N). JAD and KV are jointly chair holders of the W.K. Kellogg Chair in Cereal Science and Nutrition at KU Leuven. Technical assistance by T. Coopmans and M. Dekens is highly appreciated.</p></div></div><div id="idm140108738545616" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140108738545616title">Funding Statement</h2><p>RP is the recipient of a Ph.D. fellowship of the Research Foundation - Flanders (FWO) (grant 11E9813N) (<a href="http://www.fwo.be" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">www.fwo.be</a>). Part of the research has been funded by the Research Foundation - Flanders (FWO) (grant G077514N) (<a href="http://www.fwo.be" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">www.fwo.be</a>). JAD and KV are jointly chair holders of the W.K. Kellogg Chair in Cereal Science and Nutrition at KU Leuven (<a href="http://www.wkkf.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">www.wkkf.org</a>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><div id="idm140108773311536" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140108773311536title">Data Availability</h2><p id="__p5">All relevant data are within the paper.</p></div><div id="idm140108773195120" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140108773195120title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref001">1. <span class="mixed-citation">Meijers B, Glorieux G, Poesen R, Bakker SJ. <span class="ref-title">Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go?</span>
<span class="ref-journal">Semin Nephrol</span>
2014. 
March;<span class="ref-vol">34</span>(<span class="ref-iss">2</span>):228–43. 10.1016/j.semnephrol.2014.02.012
 [<a href="/pubmed/24780475" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.semnephrol.2014.02.012" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Nephrol&amp;title=Nonextracorporeal+methods+for+decreasing+uremic+solute+concentration:+a+future+way+to+go?&amp;author=B+Meijers&amp;author=G+Glorieux&amp;author=R+Poesen&amp;author=SJ+Bakker&amp;volume=34&amp;issue=2&amp;publication_year=2014&amp;pages=228-43&amp;pmid=24780475&amp;doi=10.1016/j.semnephrol.2014.02.012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref002">2. <span class="mixed-citation">Meyer TW, Hostetter TH. <span class="ref-title">Uremia</span>. <span class="ref-journal">N Engl J Med</span>
2007. 
September
27;<span class="ref-vol">357</span>(<span class="ref-iss">13</span>):1316–25.  [<a href="/pubmed/17898101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Uremia&amp;author=TW+Meyer&amp;author=TH+Hostetter&amp;volume=357&amp;issue=13&amp;publication_year=2007&amp;pages=1316-25&amp;pmid=17898101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref003">3. <span class="mixed-citation">Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, et al.
<span class="ref-title">Colonic contribution to uremic solutes</span>. <span class="ref-journal">J Am Soc Nephrol</span>
2011. 
September;<span class="ref-vol">22</span>(<span class="ref-iss">9</span>):1769–76. 10.1681/ASN.2010121220
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3171947/">PMC free article</a>]</span> [<a href="/pubmed/21784895" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1681%2FASN.2010121220" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Colonic+contribution+to+uremic+solutes&amp;author=PA+Aronov&amp;author=FJ+Luo&amp;author=NS+Plummer&amp;author=Z+Quan&amp;author=S+Holmes&amp;volume=22&amp;issue=9&amp;publication_year=2011&amp;pages=1769-76&amp;pmid=21784895&amp;doi=10.1681/ASN.2010121220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref004">4. <span class="mixed-citation">Meyer TW, Hostetter TH. <span class="ref-title">Uremic solutes from colon microbes</span>. <span class="ref-journal">Kidney Int</span>
2012. 
May;<span class="ref-vol">81</span>(<span class="ref-iss">10</span>):949–54. 10.1038/ki.2011.504
 [<a href="/pubmed/22318422" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fki.2011.504" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Uremic+solutes+from+colon+microbes&amp;author=TW+Meyer&amp;author=TH+Hostetter&amp;volume=81&amp;issue=10&amp;publication_year=2012&amp;pages=949-54&amp;pmid=22318422&amp;doi=10.1038/ki.2011.504&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref005">5. <span class="mixed-citation">Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. <span class="ref-title">Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients</span>. <span class="ref-journal">Kidney Int</span>
2006. 
March;<span class="ref-vol">69</span>(<span class="ref-iss">6</span>):1081–7.  [<a href="/pubmed/16421516" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Free+serum+concentrations+of+the+protein-bound+retention+solute+p-cresol+predict+mortality+in+hemodialysis+patients&amp;author=B+Bammens&amp;author=P+Evenepoel&amp;author=H+Keuleers&amp;author=K+Verbeke&amp;author=Y+Vanrenterghem&amp;volume=69&amp;issue=6&amp;publication_year=2006&amp;pages=1081-7&amp;pmid=16421516&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref006">6. <span class="mixed-citation">Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, et al.
<span class="ref-title">Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease</span>. <span class="ref-journal">Nephrol Dial Transplant</span>
2010. 
April;<span class="ref-vol">25</span>(<span class="ref-iss">4</span>):1183–91. 10.1093/ndt/gfp592
 [<a href="/pubmed/19914995" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fndt%2Fgfp592" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=Free+p-cresylsulphate+is+a+predictor+of+mortality+in+patients+at+different+stages+of+chronic+kidney+disease&amp;author=S+Liabeuf&amp;author=DV+Barreto&amp;author=FC+Barreto&amp;author=N+Meert&amp;author=G+Glorieux&amp;volume=25&amp;issue=4&amp;publication_year=2010&amp;pages=1183-91&amp;pmid=19914995&amp;doi=10.1093/ndt/gfp592&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref007">7. <span class="mixed-citation">Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P. <span class="ref-title">Free p-cresol is associated with cardiovascular disease in hemodialysis patients</span>. <span class="ref-journal">Kidney Int</span>
2008. 
May;<span class="ref-vol">73</span>(<span class="ref-iss">10</span>):1174–80. 10.1038/ki.2008.31
 [<a href="/pubmed/18305466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fki.2008.31" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Free+p-cresol+is+associated+with+cardiovascular+disease+in+hemodialysis+patients&amp;author=BK+Meijers&amp;author=B+Bammens&amp;author=B+De+Moor&amp;author=K+Verbeke&amp;author=Y+Vanrenterghem&amp;volume=73&amp;issue=10&amp;publication_year=2008&amp;pages=1174-80&amp;pmid=18305466&amp;doi=10.1038/ki.2008.31&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref008">8. <span class="mixed-citation">Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, et al.
<span class="ref-title">p-Cresol and cardiovascular risk in mild-to-moderate kidney disease</span>. <span class="ref-journal">Clin J Am Soc Nephrol</span>
2010. 
July;<span class="ref-vol">5</span>(<span class="ref-iss">7</span>):1182–9. 10.2215/CJN.07971109
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2893077/">PMC free article</a>]</span> [<a href="/pubmed/20430946" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2215%2FCJN.07971109" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=p-Cresol+and+cardiovascular+risk+in+mild-to-moderate+kidney+disease&amp;author=BK+Meijers&amp;author=K+Claes&amp;author=B+Bammens&amp;author=H+de+Loor&amp;author=L+Viaene&amp;volume=5&amp;issue=7&amp;publication_year=2010&amp;pages=1182-9&amp;pmid=20430946&amp;doi=10.2215/CJN.07971109&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref009">9. <span class="mixed-citation">Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al.
<span class="ref-title">Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients</span>. <span class="ref-journal">Clin J Am Soc Nephrol</span>
2009. 
October;<span class="ref-vol">4</span>(<span class="ref-iss">10</span>):1551–8. 10.2215/CJN.03980609
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2758258/">PMC free article</a>]</span> [<a href="/pubmed/19696217" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2215%2FCJN.03980609" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=Serum+indoxyl+sulfate+is+associated+with+vascular+disease+and+mortality+in+chronic+kidney+disease+patients&amp;author=FC+Barreto&amp;author=DV+Barreto&amp;author=S+Liabeuf&amp;author=N+Meert&amp;author=G+Glorieux&amp;volume=4&amp;issue=10&amp;publication_year=2009&amp;pages=1551-8&amp;pmid=19696217&amp;doi=10.2215/CJN.03980609&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref010">10. <span class="mixed-citation">Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, et al.
<span class="ref-title">p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease</span>. <span class="ref-journal">Nephrol Dial Transplant</span>
2011. 
March;<span class="ref-vol">26</span>(<span class="ref-iss">3</span>):938–47. 10.1093/ndt/gfq580
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3042976/">PMC free article</a>]</span> [<a href="/pubmed/20884620" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fndt%2Fgfq580" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=p-Cresyl+sulphate+and+indoxyl+sulphate+predict+progression+of+chronic+kidney+disease&amp;author=IW+Wu&amp;author=KH+Hsu&amp;author=CC+Lee&amp;author=CY+Sun&amp;author=HJ+Hsu&amp;volume=26&amp;issue=3&amp;publication_year=2011&amp;pages=938-47&amp;pmid=20884620&amp;doi=10.1093/ndt/gfq580&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref011">11. <span class="mixed-citation">Meert N, Schepers E, Glorieux G, Van LM, Goeman JL, Waterloos MA, et al.
<span class="ref-title">Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications</span>. <span class="ref-journal">Nephrol Dial Transplant</span>
2012. 
June;<span class="ref-vol">27</span>(<span class="ref-iss">6</span>):2388–96. 10.1093/ndt/gfr672
 [<a href="/pubmed/22167586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fndt%2Fgfr672" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=Novel+method+for+simultaneous+determination+of+p-cresylsulphate+and+p-cresylglucuronide:+clinical+data+and+pathophysiological+implications&amp;author=N+Meert&amp;author=E+Schepers&amp;author=G+Glorieux&amp;author=LM+Van&amp;author=JL+Goeman&amp;volume=27&amp;issue=6&amp;publication_year=2012&amp;pages=2388-96&amp;pmid=22167586&amp;doi=10.1093/ndt/gfr672&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref012">12. <span class="mixed-citation">Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al.
<span class="ref-title">Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease</span>. <span class="ref-journal">Circ Res</span>
2015. 
January
30;<span class="ref-vol">116</span>(<span class="ref-iss">3</span>):448–55. 10.1161/CIRCRESAHA.116.305360
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4312512/">PMC free article</a>]</span> [<a href="/pubmed/25599331" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1161%2FCIRCRESAHA.116.305360" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ+Res&amp;title=Gut+microbiota-dependent+trimethylamine+N-oxide+(TMAO)+pathway+contributes+to+both+development+of+renal+insufficiency+and+mortality+risk+in+chronic+kidney+disease&amp;author=WH+Tang&amp;author=Z+Wang&amp;author=DJ+Kennedy&amp;author=Y+Wu&amp;author=JA+Buffa&amp;volume=116&amp;issue=3&amp;publication_year=2015&amp;pages=448-55&amp;pmid=25599331&amp;doi=10.1161/CIRCRESAHA.116.305360&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref013">13. <span class="mixed-citation">Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, et al.
<span class="ref-title">Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden</span>. <span class="ref-journal">J Am Soc Nephrol</span>
2015.  [Epub ahead of print]. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4696571/">PMC free article</a>]</span> [<a href="/pubmed/26229137" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Serum+Trimethylamine-N-Oxide+is+Elevated+in+CKD+and+Correlates+with+Coronary+Atherosclerosis+Burden&amp;author=JR+Stubbs&amp;author=JA+House&amp;author=AJ+Ocque&amp;author=S+Zhang&amp;author=C+Johnson&amp;publication_year=2015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref014">14. <span class="mixed-citation">Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, et al.
<span class="ref-title">Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators</span>. <span class="ref-journal">PLoS One</span>
2015;<span class="ref-vol">10</span>(<span class="ref-iss">5</span>):e0126048
10.1371/journal.pone.0126048
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4418712/">PMC free article</a>]</span> [<a href="/pubmed/25938230" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0126048" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Free+Levels+of+Selected+Organic+Solutes+and+Cardiovascular+Morbidity+and+Mortality+in+Hemodialysis+Patients:+Results+from+the+Retained+Organic+Solutes+and+Clinical+Outcomes+(ROSCO)+Investigators&amp;author=T+Shafi&amp;author=TW+Meyer&amp;author=TH+Hostetter&amp;author=ML+Melamed&amp;author=RS+Parekh&amp;volume=10&amp;issue=5&amp;publication_year=2015&amp;pages=e0126048&amp;pmid=25938230&amp;doi=10.1371/journal.pone.0126048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref015">15. <span class="mixed-citation">Poesen R, Meijers B, Evenepoel P. <span class="ref-title">The Colon: An Overlooked Site for Therapeutics in Dialysis Patients</span>. <span class="ref-journal">Semin Dial</span>
2013. 
March
4;<span class="ref-vol">26</span>:323–32. 10.1111/sdi.12082
 [<a href="/pubmed/23458264" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fsdi.12082" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Dial&amp;title=The+Colon:+An+Overlooked+Site+for+Therapeutics+in+Dialysis+Patients&amp;author=R+Poesen&amp;author=B+Meijers&amp;author=P+Evenepoel&amp;volume=26&amp;publication_year=2013&amp;pages=323-32&amp;pmid=23458264&amp;doi=10.1111/sdi.12082&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref016">16. <span class="mixed-citation">Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al.
<span class="ref-title">Prebiotic effects: metabolic and health benefits</span>. <span class="ref-journal">Br J Nutr</span>
2010. 
August;<span class="ref-vol">104</span>
<span class="ref-iss">Suppl 2</span>:S1–63. 10.1017/S0007114510003363
 [<a href="/pubmed/20920376" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1017%2FS0007114510003363" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Nutr&amp;title=Prebiotic+effects:+metabolic+and+health+benefits&amp;author=M+Roberfroid&amp;author=GR+Gibson&amp;author=L+Hoyles&amp;author=AL+McCartney&amp;author=R+Rastall&amp;volume=104&amp;issue=Suppl+2&amp;publication_year=2010&amp;pages=S1-63&amp;pmid=20920376&amp;doi=10.1017/S0007114510003363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref017">17. <span class="mixed-citation">Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P. <span class="ref-title">p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin</span>. <span class="ref-journal">Nephrol Dial Transplant</span>
2010. 
January;<span class="ref-vol">25</span>(<span class="ref-iss">1</span>):219–24. 10.1093/ndt/gfp414
 [<a href="/pubmed/19692415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fndt%2Fgfp414" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=p-Cresyl+sulfate+serum+concentrations+in+haemodialysis+patients+are+reduced+by+the+prebiotic+oligofructose-enriched+inulin&amp;author=BK+Meijers&amp;author=V+De+Preter&amp;author=K+Verbeke&amp;author=Y+Vanrenterghem&amp;author=P+Evenepoel&amp;volume=25&amp;issue=1&amp;publication_year=2010&amp;pages=219-24&amp;pmid=19692415&amp;doi=10.1093/ndt/gfp414&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref018">18. <span class="mixed-citation">Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. <span class="ref-title">Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients</span>. <span class="ref-journal">Clin J Am Soc Nephrol</span>
2014. 
September
5;<span class="ref-vol">9</span>(<span class="ref-iss">9</span>):1603–10. 10.2215/CJN.00490114
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4152802/">PMC free article</a>]</span> [<a href="/pubmed/25147155" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2215%2FCJN.00490114" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=Effect+of+increasing+dietary+fiber+on+plasma+levels+of+colon-derived+solutes+in+hemodialysis+patients&amp;author=TL+Sirich&amp;author=NS+Plummer&amp;author=CD+Gardner&amp;author=TH+Hostetter&amp;author=TW+Meyer&amp;volume=9&amp;issue=9&amp;publication_year=2014&amp;pages=1603-10&amp;pmid=25147155&amp;doi=10.2215/CJN.00490114&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref019">19. <span class="mixed-citation">Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, et al.
<span class="ref-title">p-Cresyl sulfate promotes insulin resistance associated with CKD</span>. <span class="ref-journal">J Am Soc Nephrol</span>
2013. 
January;<span class="ref-vol">24</span>(<span class="ref-iss">1</span>):88–99. 10.1681/ASN.2012050503
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3537215/">PMC free article</a>]</span> [<a href="/pubmed/23274953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1681%2FASN.2012050503" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=p-Cresyl+sulfate+promotes+insulin+resistance+associated+with+CKD&amp;author=L+Koppe&amp;author=NJ+Pillon&amp;author=RE+Vella&amp;author=ML+Croze&amp;author=CC+Pelletier&amp;volume=24&amp;issue=1&amp;publication_year=2013&amp;pages=88-99&amp;pmid=23274953&amp;doi=10.1681/ASN.2012050503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref020">20. <span class="mixed-citation">Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA. <span class="ref-title">Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides</span>. <span class="ref-journal">Crit Rev Food Sci Nutr</span>
2011. 
February;<span class="ref-vol">51</span>(<span class="ref-iss">2</span>):178–94. 10.1080/10408390903044768
 [<a href="/pubmed/21328111" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F10408390903044768" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Food+Sci+Nutr&amp;title=Prebiotic+and+other+health-related+effects+of+cereal-derived+arabinoxylans,+arabinoxylan-oligosaccharides,+and+xylooligosaccharides&amp;author=WF+Broekaert&amp;author=CM+Courtin&amp;author=K+Verbeke&amp;author=T+Van+de+Wiele&amp;author=W+Verstraete&amp;volume=51&amp;issue=2&amp;publication_year=2011&amp;pages=178-94&amp;pmid=21328111&amp;doi=10.1080/10408390903044768&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref021">21. <span class="mixed-citation">Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, et al.
<span class="ref-title">Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study</span>. <span class="ref-journal">Br J Nutr</span>
2010. 
March;<span class="ref-vol">103</span>(<span class="ref-iss">5</span>):703–13. 10.1017/S0007114509992248
 [<a href="/pubmed/20003568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1017%2FS0007114509992248" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Nutr&amp;title=Tolerance+of+arabinoxylan-oligosaccharides+and+their+prebiotic+activity+in+healthy+subjects:+a+randomised,+placebo-controlled+cross-over+study&amp;author=L+Cloetens&amp;author=WF+Broekaert&amp;author=Y+Delaedt&amp;author=F+Ollevier&amp;author=CM+Courtin&amp;volume=103&amp;issue=5&amp;publication_year=2010&amp;pages=703-13&amp;pmid=20003568&amp;doi=10.1017/S0007114509992248&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref022">22. <span class="mixed-citation">Damen B, Cloetens L, Broekaert WF, Francois I, Lescroart O, Trogh I, et al.
<span class="ref-title">Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers</span>. <span class="ref-journal">J Nutr</span>
2012. 
March;<span class="ref-vol">142</span>(<span class="ref-iss">3</span>):470–7. 10.3945/jn.111.146464
 [<a href="/pubmed/22298569" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.3945%2Fjn.111.146464" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Nutr&amp;title=Consumption+of+breads+containing+in+situ-produced+arabinoxylan+oligosaccharides+alters+gastrointestinal+effects+in+healthy+volunteers&amp;author=B+Damen&amp;author=L+Cloetens&amp;author=WF+Broekaert&amp;author=I+Francois&amp;author=O+Lescroart&amp;volume=142&amp;issue=3&amp;publication_year=2012&amp;pages=470-7&amp;pmid=22298569&amp;doi=10.3945/jn.111.146464&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref023">23. <span class="mixed-citation">Francois IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, et al.
<span class="ref-title">Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial</span>. <span class="ref-journal">Br J Nutr</span>
2012. 
February
28;1–14. [<a href="/pubmed/22370444" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Nutr&amp;title=Effects+of+a+wheat+bran+extract+containing+arabinoxylan+oligosaccharides+on+gastrointestinal+health+parameters+in+healthy+adult+human+volunteers:+a+double-blind,+randomised,+placebo-controlled,+cross-over+trial&amp;author=IE+Francois&amp;author=O+Lescroart&amp;author=WS+Veraverbeke&amp;author=M+Marzorati&amp;author=S+Possemiers&amp;publication_year=2012&amp;pages=1-14&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref024">24. <span class="mixed-citation">Francois IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Hamer H, et al.
<span class="ref-title">Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children</span>. <span class="ref-journal">J Pediatr Gastroenterol Nutr</span>
2014. 
May;<span class="ref-vol">58</span>(<span class="ref-iss">5</span>):647–53. 10.1097/MPG.0000000000000285
 [<a href="/pubmed/24368315" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2FMPG.0000000000000285" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr+Gastroenterol+Nutr&amp;title=Effects+of+wheat+bran+extract+containing+arabinoxylan+oligosaccharides+on+gastrointestinal+parameters+in+healthy+preadolescent+children&amp;author=IE+Francois&amp;author=O+Lescroart&amp;author=WS+Veraverbeke&amp;author=M+Marzorati&amp;author=S+Possemiers&amp;volume=58&amp;issue=5&amp;publication_year=2014&amp;pages=647-53&amp;pmid=24368315&amp;doi=10.1097/MPG.0000000000000285&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref025">25. <span class="mixed-citation">Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al.
<span class="ref-title">Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate</span>. <span class="ref-journal">Ann Intern Med</span>
2006. 
August
15;<span class="ref-vol">145</span>(<span class="ref-iss">4</span>):247–54.  [<a href="/pubmed/16908915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Using+standardized+serum+creatinine+values+in+the+modification+of+diet+in+renal+disease+study+equation+for+estimating+glomerular+filtration+rate&amp;author=AS+Levey&amp;author=J+Coresh&amp;author=T+Greene&amp;author=LA+Stevens&amp;author=YL+Zhang&amp;volume=145&amp;issue=4&amp;publication_year=2006&amp;pages=247-54&amp;pmid=16908915&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref026">26. <span class="mixed-citation">Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. <span class="ref-title">Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</span>. <span class="ref-journal">Diabetologia</span>
1985. 
July;<span class="ref-vol">28</span>(<span class="ref-iss">7</span>):412–9.  [<a href="/pubmed/3899825" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Homeostasis+model+assessment:+insulin+resistance+and+beta-cell+function+from+fasting+plasma+glucose+and+insulin+concentrations+in+man&amp;author=DR+Matthews&amp;author=JP+Hosker&amp;author=AS+Rudenski&amp;author=BA+Naylor&amp;author=DF+Treacher&amp;volume=28&amp;issue=7&amp;publication_year=1985&amp;pages=412-9&amp;pmid=3899825&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref027">27. <span class="mixed-citation">Salmean YA, Segal MS, Palii SP, Dahl WJ. <span class="ref-title">Fiber Supplementation Lowers Plasma p-Cresol in Chronic Kidney Disease Patients</span>. <span class="ref-journal">J Ren Nutr</span>
2014. 
November
5;<span class="ref-vol">25</span>:316–20. 10.1053/j.jrn.2014.09.002
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4646076/">PMC free article</a>]</span> [<a href="/pubmed/25446837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1053%2Fj.jrn.2014.09.002" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Ren+Nutr&amp;title=Fiber+Supplementation+Lowers+Plasma+p-Cresol+in+Chronic+Kidney+Disease+Patients&amp;author=YA+Salmean&amp;author=MS+Segal&amp;author=SP+Palii&amp;author=WJ+Dahl&amp;volume=25&amp;publication_year=2014&amp;pages=316-20&amp;pmid=25446837&amp;doi=10.1053/j.jrn.2014.09.002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0153893.ref028">28. <span class="mixed-citation">Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, et al.
<span class="ref-title">The Influence of CKD on Colonic Microbial Metabolism</span>. <span class="ref-journal">J Am Soc Nephrol</span>
2015.  [Epub ahead of print]. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4849823/">PMC free article</a>]</span> [<a href="/pubmed/26400570" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=The+Influence+of+CKD+on+Colonic+Microbial+Metabolism&amp;author=R+Poesen&amp;author=K+Windey&amp;author=E+Neven&amp;author=D+Kuypers&amp;author=V+De+Preter&amp;publication_year=2015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2" style=""><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140108733446464title">Abstract</a></li><li><a href="#sec001title">Introduction</a></li><li><a href="#sec002title">Materials and Methods</a></li><li><a href="#sec009title">Results</a></li><li><a href="#sec014title">Discussion</a></li><li><a href="#sec015title">Supporting Information</a></li><li><a href="#idm140108773196160title">Acknowledgments</a></li><li><a href="#idm140108738545616title">Funding Statement</a></li><li><a href="#idm140108773311536title">Data Availability</a></li><li><a href="#idm140108773195120title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4839737/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4839737/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4839737/pdf/pone.0153893.pdf">PDF (1.0M)</a></li> | <li><a href="#" data-citationid="PMC4839737" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4839737%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4839737%2F&amp;text=The%20Influence%20of%20Prebiotic%20Arabinoxylan%20Oligosaccharides%20on%20Microbiota%20Derived%20Uremic%20Retention%20Solutes%20in%20Patients%20with%20Chronic%20Kidney%20Disease%3A%20A%20Randomized%20Controlled%20Trial" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4839737%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="27100399" data-aiid="4839737" data-aid="4839737" data-iid="267609" data-domainid="440" data-domain="plosone" data-accid="PMC4839737" data-md5="a9bf3bcf04bcfc697bf36b445eae297e">

<div>







</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-pone.0153893.ref001" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go?<div class="authors">Meijers B, Glorieux G, Poesen R, Bakker SJ</div><div class="citation">Semin Nephrol. 2014 Mar; 34(2):228-43.</div><p>[<a href="/pubmed/24780475/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref001">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref002" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Uremia.<div class="authors">Meyer TW, Hostetter TH</div><div class="citation">N Engl J Med. 2007 Sep 27; 357(13):1316-25.</div><p>[<a href="/pubmed/17898101/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref002">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref003" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Colonic contribution to uremic solutes.<div class="authors">Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW</div><div class="citation">J Am Soc Nephrol. 2011 Sep; 22(9):1769-76.</div><p>[<a href="/pubmed/21784895/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref003">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref004" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Uremic solutes from colon microbes.<div class="authors">Meyer TW, Hostetter TH</div><div class="citation">Kidney Int. 2012 May; 81(10):949-954.</div><p>[<a href="/pubmed/22318422/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref004">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref005" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.<div class="authors">Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y</div><div class="citation">Kidney Int. 2006 Mar; 69(6):1081-7.</div><p>[<a href="/pubmed/16421516/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref005">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref010" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.<div class="authors">Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, Tzen CY, Wang YC, Lin CY, Wu MS</div><div class="citation">Nephrol Dial Transplant. 2011 Mar; 26(3):938-47.</div><p>[<a href="/pubmed/20884620/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref010">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref011" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.<div class="authors">Meert N, Schepers E, Glorieux G, Van Landschoot M, Goeman JL, Waterloos MA, Dhondt A, Van der Eycken J, Vanholder R</div><div class="citation">Nephrol Dial Transplant. 2012 Jun; 27(6):2388-96.</div><p>[<a href="/pubmed/22167586/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref011">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref012" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.<div class="authors">Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL</div><div class="citation">Circ Res. 2015 Jan 30; 116(3):448-55.</div><p>[<a href="/pubmed/25599331/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref012">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref014" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.<div class="authors">Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR</div><div class="citation">PLoS One. 2015; 10(5):e0126048.</div><p>[<a href="/pubmed/25938230/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref014">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref015" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The colon: an overlooked site for therapeutics in dialysis patients.<div class="authors">Poesen R, Meijers B, Evenepoel P</div><div class="citation">Semin Dial. 2013 May-Jun; 26(3):323-32.</div><p>[<a href="/pubmed/23458264/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref015">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref016" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Prebiotic effects: metabolic and health benefits.<div class="authors">Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A</div><div class="citation">Br J Nutr. 2010 Aug; 104 Suppl 2():S1-63.</div><p>[<a href="/pubmed/20920376/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref016">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref017" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.<div class="authors">Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P</div><div class="citation">Nephrol Dial Transplant. 2010 Jan; 25(1):219-24.</div><p>[<a href="/pubmed/19692415/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref017">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref018" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.<div class="authors">Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW</div><div class="citation">Clin J Am Soc Nephrol. 2014 Sep 5; 9(9):1603-10.</div><p>[<a href="/pubmed/25147155/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref018">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref019" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">p-Cresyl sulfate promotes insulin resistance associated with CKD.<div class="authors">Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, Massy Z, Glorieux G, Vanholder R, Dugenet Y, Soula HA, Fouque D, Soulage CO</div><div class="citation">J Am Soc Nephrol. 2013 Jan; 24(1):88-99.</div><p>[<a href="/pubmed/23274953/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref019">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref020" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides.<div class="authors">Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA</div><div class="citation">Crit Rev Food Sci Nutr. 2011 Feb; 51(2):178-94.</div><p>[<a href="/pubmed/21328111/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref020">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref023" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial.<div class="authors">François IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, Hamer H, Houben E, Windey K, Welling GW, Delcour JA, Courtin CM, Verbeke K, Broekaert WF</div><div class="citation">Br J Nutr. 2012 Dec 28; 108(12):2229-42.</div><p>[<a href="/pubmed/22370444/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref023">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref024" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children.<div class="authors">François IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Hamer H, Windey K, Welling GW, Delcour JA, Courtin CM, Verbeke K, Broekaert WF</div><div class="citation">J Pediatr Gastroenterol Nutr. 2014 May; 58(5):647-53.</div><p>[<a href="/pubmed/24368315/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref024">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref025" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.<div class="authors">Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration.</div><div class="citation">Ann Intern Med. 2006 Aug 15; 145(4):247-54.</div><p>[<a href="/pubmed/16908915/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref025">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref026" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.<div class="authors">Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC</div><div class="citation">Diabetologia. 1985 Jul; 28(7):412-9.</div><p>[<a href="/pubmed/3899825/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref026">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref027" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.<div class="authors">Salmean YA, Segal MS, Palii SP, Dahl WJ</div><div class="citation">J Ren Nutr. 2015 May; 25(3):316-20.</div><p>[<a href="/pubmed/25446837/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref027">Ref list</a>]</p></div><div id="body-link-popper-pone.0153893.ref028" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The Influence of CKD on Colonic Microbial Metabolism.<div class="authors">Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, D'Haese P, Evenepoel P, Verbeke K, Meijers B</div><div class="citation">J Am Soc Nephrol. 2016 May; 27(5):1389-99.</div><p>[<a href="/pubmed/26400570/" ref="reftype=pubmed&amp;article-id=4839737&amp;issue-id=267609&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0153893.ref028">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 64px; left: 459px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=plosone&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC4839737/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 95B63906E70AD421_0000SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></htm
